Home/Publication/Kotak Funds Matrix Pharma’s Acquisition of API Business
Kotak Funds Matrix Pharma’s Acquisition of API Business 

12 Jun 2024

US$ 19.00

Kotak Alternate Asset Managers Ltd, through its Kotak Strategic Situations Fund II, has injected 14.5 billion rupees...

Price / article: US$19.00
OR existing subscriber
Related Publications
Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.